In Re Neurontin Marketing, Sales Practices and Products Liability Litigation
District Court, D. Massachusetts
Bulger v. Pfizer, Inc., et al.,
1Opinion of the Court
MEMORANDUM AND ORDER
SARIS, District Judge.
I. INTRODUCTION
This multi-district litigation involves over 100 plaintiffs who allege they, or their decedents, suffered suicide-related injuries after their doctors prescribed the drug Neurontin, manufactured by defendants Pfizer Inc. and Warner-Lambert Company LLC (collectively “Pfizer”). Plaintiffs allege that defendants engaged in a fraudulent scheme to market Neurontin for “off-label” uses not approved by the Food and Drug Administration (FDA). Among other things, they allege that defendants’ employees and sales representatives fraudulently…
2Cases cited48 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
- Wyeth v. LevineSupreme Court of the United States · 2009
- Chiarella v. United StatesSupreme Court of the United States · 1980
- Dorsey v. Portfolio Equities, Inc.Court of Appeals for the Fifth Circuit · 2008
43 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- Taylor v. American Chemistry CouncilCourt of Appeals for the First Circuit · 2009
- Smith v. PFIZER INC.District Court, M.D. Tennessee · 2010
- Commonwealth v. Tap Pharmaceutical Products, Inc.Commonwealth Court of Pennsylvania · 2011
- Commonwealth v. Tap Pharmaceutical Products, Inc.Commonwealth Court of Pennsylvania · 2011
- Smith v. Pfizer Inc.District Court, M.D. Tennessee · 2010
10 more not listed; retrieve them via the Exa API.